Short description
Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics.
Description
Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics. Its Amphivena ReSTORE platform provides dual-action biologics that relieve immune suppression and activate T cell effector function in cancer patients. The platform design integrates elements of avidity, target selectivity, and enhanced safety within a single molecule. It is also can be engineered with additional solid tumor targeting modalities to add functionality such as directed tumor cell killing.
It was founded in 2012 and is headquartered in South San Francisco, California.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
South San Francisco, California, United States, North America
Founded on
January 1, 2012
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Nopepepe, Nopepepe, Cannot Access, Noaccess, Uh Ohhhh, Nopepepe, Noaccess, Noaccessforu, Absolutely Noaccess, Noway Youcantaccess, Absolutely Noaccess, Blurry Noaccess, Blurry Noaccess, Uh Ohhhh
Sign in for full access
Founders
Luke Evnin